A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006
A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018
The association of lung cancer with pulmonary fibrosis Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021 Year: 2022
Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Initial combined intratumoral chemotherapy with cisplatin and irradiation for inoperable non-small cell obstructive lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 492s Year: 2004
The safety and efficacy of treatment with nab-paclitaxel and carboplatin for patients with advanced squamous non-small cell lung cancer with interstitial lung disease. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Outcome of treated advanced non-small cell lung cancer associated with central airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 796s Year: 2006
Bilateral lung cancer with COPD or metastatic disease Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology Year: 2016
Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004
Characteristics of radiation pneumonitis and lung function after curatively intended radiotherapy in non-small cell lung carcinoma Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
How to treat lung cancer in IPF patients Source: Research Seminar 2015 Year: 2015
Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease. Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018